The iron homeostasis network and hepatitis C virus - a new challenge in the era of directly acting antivirals.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

1. Iron as a therapeutic target in chronic liver disease.World journal of gastroenterology · 2023
   Review
2. Multi-Omics Sequencing Provides Insights Into Age-Dependent Susceptibility of Grass Carp (Frontiers in immunology · 2021
   Article
3. Iron and liver fibrosis: Mechanistic and clinical aspects.World journal of gastroenterology · 2019
   Review
4. Differences in responses of grass carp to different types of grass carp reovirus (GCRV) and the mechanism of hemorrhage revealed by transcriptome sequencing.BMC genomics · 2017
   Article

Corrections and comments

• Comment on
  Alterations in the iron homeostasis network: A driving force for macrophage-mediated hepatitis C virus persistency.2016

Authors and funding

1 author at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as